SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-045033
Filing Date
2023-12-15
Accepted
2023-12-15 15:50:02
Documents
13
Period of Report
2023-12-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48389
  Complete submission text file 0001493152-23-045033.txt   264582

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ptix-20231213.xsd EX-101.SCH 3516
3 XBRL DEFINITION FILE ptix-20231213_def.xml EX-101.DEF 26547
4 XBRL LABEL FILE ptix-20231213_lab.xml EX-101.LAB 36501
5 XBRL PRESENTATION FILE ptix-20231213_pre.xml EX-101.PRE 25171
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4987
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12555 | Film No.: 231490124
SIC: 2834 Pharmaceutical Preparations